Wegovy's Cardiovascular Efficacy Uncovered
Study in The Lancet found benefits regardless of weight loss.
Waist circumference reduction explained 33% of heart event benefit.
Each 5cm waist drop linked to 9% lower heart risk.
NHS will provide Wegovy to 240,000 in England.
UK regulator approved Wegovy for broader use.